We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ARSUF market cap is 1.36B. The company's latest EPS is EUR 0.9634 and P/E is 19.27.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 536.4M | 556.99M | 577.55M | 694.42M | 766.48M |
| Operating Income | 73.4M | 89.11M | 87.79M | 98.02M | 109.51M |
| Net Income | 41.06M | 59.6M | 61M | 69.61M | 70.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 801.24M | 752.83M | 800.42M | 971.01M | 1.01B |
| Total Liabilities | 554.8M | 495.01M | 474.96M | 560.49M | 539.33M |
| Total Equity | 246.44M | 257.82M | 325.47M | 410.52M | 467.63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 77.18M | 92.95M | 78.42M | 109.46M | 124.63M |
| Investing | -43.59M | -51.3M | -31.92M | -69.27M | -44.76M |
| Financing | -4.49M | -53.11M | -61.65M | 13.85M | -74.28M |
| Market Cap | 1.36B |
| Price to Earnings Ratio | 19.27 |
| Price to Sales Ratio | 1.77 |
| Price to Cash Ratio | 10.22 |
| Price to Book Ratio | 2.91 |
| Dividend Yield | - |
| Shares Outstanding | 73.23M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 15.10% |
| 52 Week High | 20.5961 |
| 52 Week Low | 16.15 |
| Spread (Intraday) | 105.45 (87.57%) |
| Company Name | Fagron SA (PK) |
| Address |
fascinatio boulevard350 roermond, limburg 3065 WB |
| Website | https://www.fagron.com |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
